Hong Kong pharmaceutical distribution stocks continued to fall. Pharmacist Bang fell nearly 6%, DaHealth International and Shanghai Pharmaceuticals all fell by more than 3%, and Sinopharm Holdings fell 2.5%.
Hong Kong pharmaceutical distribution stocks continued to fall. Pharmacist Bang fell nearly 6%, DaHealth International and Shanghai Pharmaceuticals all fell by more than 3%, and Sinopharm Holdings fell 2.5%.
An advertisement for Le Pharmacist Agastache Zhengqi Oral Liquid appeared on CCTV, and Pharmacist helped push ahead with the first big single product strategy
Gelonghui, May 20 | Recently, Pharmacist helped its own brand Le Pharmacist Agastache Zhengqi Oral Liquid appeared on CCTV, focusing on advantageous selling points such as the product “0 alcohol, lightweight and portable, ready to drink” to promote the strong entry of large Agastache products into the market during the season. This round of marketing covers CCTV's golden resources such as 1, 2, and 4 sets, and locks in the prime time period for each channel. The broadcast cycle will continue from May to December to achieve high frequency, wide coverage, and deep audience reach. According to Zhongkang CHIS data, the overall scale of agastache products in the out-of-hospital market reached 3.24 billion yuan in 2023, of which the oral liquid dosage scale reached 1,874 billion yuan
Meta Group Limited sold 16.4 million shares of YSB Inc. (09885.HK) common shares worth approximately HK$137 million off the market, actually
On May 17, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on May 17, Meta Group Limited sold $16.4 million shares of $Pharmacist Bang (09885.HK) on May 13 at an average price of HK$8.35 per share, worth approximately HK$137 million. After the sale, Meta Group Limited's latest shareholding was 65,538,600 shares, and the good position ratio dropped from 12.78% to 10.23%. Photo Source: Stock Exchange Equity Disclosure What is equity disclosure? According to the requirements of the Hong Kong Stock Exchange, large stocks
Pharmacists helped their own brand “Le Pharmacist” sell over 100 varieties and purchased more than 300,000 customers
From May 8 to May 6, Ge Longhui's official information revealed that as of April of this year, its own brand “Le Pharmacist” had surpassed 100, officially entering a new era of Baipin; the cumulative number of purchasing customers of “Le Pharmacist” has also exceeded 300,000, becoming a new force in terminal pharmaceutical sales. According to information, on the basis of the brand's first launch in 2023, Pharmacist Help tried the reverse flexible customization model of their own brand “Le Pharmacist”, gather downstream pharmacies and medical needs, and link upstream pharmaceutical companies through the platform to achieve customized production. Le Pharmacist focuses on everyday consumer medication scenarios for common diseases to provide consumers with a full range of products
Pharmacists helped further speed up user coverage. From January to April, the number of users in primary care institutions increased by more than 40,000
Gelonghui, May 7 | Pharmacist Help released official information on May 6, stating that from January to April 2024, the number of new primary care institution users exceeded 40,000. According to information, over the past two years, Pharmacist Help has continued to accelerate the introduction of primary care institution users: in 2022, the company added a total of about 30,000 new primary care institution users; in 2023, the company added more than 70,000 new primary care institution users. As of December 31, 2023, Pharmacist Help has covered about 246,000 primary care institutions. Since this year, pharmacists have helped focus on developing and covering primary medical institutions to increase their penetration
Express News | Pharmacist helps buy back 200,000 shares for two consecutive days
YSB Trustee Buys Back Shares For Incentive Scheme
YSB (HKG:9885), through its trustee, repurchased 100,000 of the pharmaceuticals sales platform's shares at HK$8.21 apiece for HK$821,186, according to a Wednesday filing with the Hong Kong bourse. The
Pharmacist Gang (09885.HK): Trustee buys back 100,000 shares according to share incentive plan
Gelonghui, April 24, 丨 Pharmacist Gang (09885.HK) issued an announcement. On April 24, 2024, according to the trust arrangement between the company and the trust agency, the trustee bought back 100,000 shares of the company on the market to meet the rewards granted under the share incentive plan. The total cost was HK$821,186, with an average price of HK$8.21 per share. Under the share incentive plan, the company may direct the trustee to make further repurchases of additional shares, and from time to time publish separate voluntary announcements regarding the relevant repurchases. The board of directors believes that the company's current stock price is lower than its intrinsic value and may not fully reflect the public
YSB Widens Loss by 114% in 2023
YSB (HKG:9885) recorded a 114% rise in attributable loss for the year ended Dec. 31, 2023, to 3.19 billion yuan from 1.49 billion yuan during the year-ago period, a Friday filing on the Hong Kong bour
藥師幫:2023年報
The first annual report of the listing was unveiled, and the growth flywheel of Pharmacist Gang (9885.HK) turned
With the deep integration of Internet technology and the rise of artificial intelligence technology in recent years, the out-of-hospital pharmaceutical industry, as an important part of the healthcare field, has ushered in unprecedented changes.
Pharmacist Gang (09885): The adjusted net profit for 2023 was fully corrected, with outstanding performance and outstanding growth value
In 2023, Pharmacist Help achieved operating income of 16.972 billion yuan, annual adjusted net profit of 131 million yuan, operating cash inflow of over 459.5%, and steady growth in performance.
Hong Kong stock changes丨Pharmacists helped open up nearly 5%, and net profit was fully adjusted to exceed 130 million yuan for the first time in 2023
Glonghui March 12 | Pharmacist Gang (9885.HK) opened 4.97% to HK$10.98, rising for the 5th day in a row, and its stock price hit a new high since December 18 last year. The latest market value was HK$7.033 billion. According to the news, the company announced its 2023 annual results announcement last night, showing that for the whole of 2023, Pharmacist Help's GMV reached 46.91 billion yuan, up 24% year on year; operating income was 16.97 billion yuan, up 18.9% year on year; gross profit was 1.74 billion yuan, up 21.3% year on year; and annual adjusted net profit was fully adjusted to 130 million yuan, compared with year 22-
Pharmacist Gang (9885.HK): Total GMV reached 46.9 billion yuan in 2023, revenue of 16.97 billion yuan, and adjusted net profit completely changed to over 130 million yuan for the first time
On March 11, Pharmacist Gang (9885.HK) announced the 2023 annual results. According to the announcement, throughout 2023, Pharmacist Bank's GMV reached 46.91 billion yuan, up 24% year on year; operating income was 16.97 billion yuan, up 18.9% year on year; gross profit was 1.74 billion yuan, up 21.3% year on year; annual adjusted net profit reached 130 million yuan, up -125 million yuan year on year 22, achieving the first large-scale annual operating profit in history; operating cash inflow exceeded 450 million yuan, and profitability continued to increase steadily. Business collaboration drives performance growth, scale advantage
Announcement Highlights: China Resources Land's contract sales fell nearly 50% year on year in the first 2 months; CIMC Auto plans to buy back all H shares at a premium of about 4.90%
Pharmacist Help released annual results, with revenue of about 16.972 billion yuan, up 18.9% year on year; Sinopec Oil Service Performance Report: 2023 net profit of 590 million yuan, up 23.8% year on year; Lai Kai Pharmaceutical-B submitted a clinical trial application for a new drug for obesity to the US Food and Drug Administration.
Hong Kong Stock Announcement Nuggets | SF Express Tongcheng expects net profit from continuing operations to be no less than 60 million yuan in 2023
ESR's subsidiary interests in the proposed sale of ARA's private equity business are expected to achieve revenue of about 50 million US dollars; Glory Pharmaceutical-B announced that it will present the final results of the Phase II study of the FASN inhibitor ASC40 to treat acne at the 2024 American Academy of Dermatology (AAD) annual meeting
Pharmacist Gang (09885) released annual results, with revenue of about 16.972 billion yuan, an increase of 18.9% over the previous year
Pharmacist Bang (09885) announced its annual results for the year ended December 31, 2023, with revenue of approximately RMB 16.972 billion (RMB, same below), up 18.9% year on year; gross profit of RMB 1,741 billion, up 21.3% year on year; adjusted net profit of about RMB 131 million, while the total volume of commodity transactions reached RMB 46.912 billion, up 24% year on year.
Pharmacist Help's 2023 annual results: total GMV reached 46.9 billion yuan, an increase of 24%, and adjusted net profit changed to 130 million yuan
Pharmacist Gang (9885.HK), the largest digital service platform for the out-of-hospital pharmaceutical industry in China, released its 2023 annual performance report. During the reporting period, total GMV reached 46.91 billion yuan, up 24% year on year; operating income was 16.97 billion yuan, up 18.9% year on year; gross profit was 1.74 billion yuan, up 21.3% year on year; adjusted annual net profit was fully adjusted to 130 million yuan, and operating cash inflow exceeded 450 million yuan. Among them, the synergy effect of the “platform+self-operated” business was further amplified. According to the report, there are 8,100 retail merchants on the Pharmacist Help platform, and there are over 3.6 million sellable SKUs
YSB: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Changes in Hong Kong stocks | Pharmacist Gang (09885) rose more than 8%, and the subsidiary plans to invest 10 million yuan to obtain 13% benefits from Rui Ze Health
Pharmacist Bang (09885) rose more than 8%. As of press release, it rose 8.35% to HK$8.82, with a turnover of HK$17017,800.
No Data